Regeneron Pharmaceuticals, Inc.
Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases.
We are a company founded in the pursuit of more. More science, more questions, more answers, more options and more hope. Because the more we know, the more focused our solutions will be, and the more we can help those who need it most.
At Regeneron, we move science to medicine because our world is meant for more. https://www.regeneron.com
-
Patients aren’t just patients. They’re our loved ones, too. Everything we deliver must be of the highest quality, even and especially as we strive to deliver uninterrupted supply.
It can be a tricky balance to strive for the highest quality possible at the same time we want an uninterrupted supply. It means rewarding people who bring up issues, even if it might affect supply goals. Our culture isn’t punitive. We always want to understand why things went wrong.Patrice Gilooly, Senior Vice President, Quality Assurance and Operations -
We had an entirely new marketing team, with the longest-tenured member having six years of experience. We found ourselves faced with an FDA approval after 3.5 months of review. It was the most challenging task I have ever encountered. We were building the plane while it was flying — while sourcing parts and reading the blueprints on how to put it together. Yet we were able to successfully launch with incredible results that exceeded all expectations.
John Bae, Associate Director of Marketing, Commercial -
We have an optimistic and highly collaborative approach to solving problems. When we experience failures — and there are a lot of them! — we don’t get down. We say, “Let’s go back and think about what we can change.” And we have multiple approaches going simultaneously, which is very Regeneron. We don’t limit ourselves to one way of doing things.
Lynn Macdonald, Vice President, Neuroscience, VI NEXT®, MPDS, BiCS, DNA Core & Automation
